Matches in SemOpenAlex for { <https://semopenalex.org/work/W3018289581> ?p ?o ?g. }
- W3018289581 endingPage "920" @default.
- W3018289581 startingPage "910" @default.
- W3018289581 abstract "Long-acting cabotegravir (CAB) extends antiretroviral drug administration from daily to monthly. However, dosing volumes, injection site reactions and health-care oversight are obstacles towards a broad usage. The creation of poloxamer-coated hydrophobic and lipophilic CAB prodrugs with controlled hydrolysis and tissue penetrance can overcome these obstacles. To such ends, fatty acid ester CAB nanocrystal prodrugs with 14, 18 and 22 added carbon chains were encased in biocompatible surfactants named NMCAB, NM2CAB and NM3CAB and tested for drug release, activation, cytotoxicity, antiretroviral activities, pharmacokinetics and biodistribution. Pharmacokinetics studies, performed in mice and rhesus macaques, with the lead 18-carbon ester chain NM2CAB, showed plasma CAB levels above the protein-adjusted 90% inhibitory concentration for up to a year. NM2CAB, compared with NMCAB and NM3CAB, demonstrated a prolonged drug release, plasma circulation time and tissue drug concentrations after a single 45 mg per kg body weight intramuscular injection. These prodrug modifications could substantially improve CAB's effectiveness." @default.
- W3018289581 created "2020-05-01" @default.
- W3018289581 creator A5006263846 @default.
- W3018289581 creator A5012857107 @default.
- W3018289581 creator A5018546819 @default.
- W3018289581 creator A5021809794 @default.
- W3018289581 creator A5023736838 @default.
- W3018289581 creator A5025385383 @default.
- W3018289581 creator A5027982894 @default.
- W3018289581 creator A5029066855 @default.
- W3018289581 creator A5035613509 @default.
- W3018289581 creator A5043422961 @default.
- W3018289581 creator A5051999877 @default.
- W3018289581 creator A5057200036 @default.
- W3018289581 creator A5058974129 @default.
- W3018289581 creator A5059564746 @default.
- W3018289581 creator A5060090611 @default.
- W3018289581 creator A5060883440 @default.
- W3018289581 creator A5061418721 @default.
- W3018289581 creator A5064955974 @default.
- W3018289581 creator A5065113476 @default.
- W3018289581 creator A5072603735 @default.
- W3018289581 creator A5076498300 @default.
- W3018289581 date "2020-04-27" @default.
- W3018289581 modified "2023-10-06" @default.
- W3018289581 title "A year-long extended release nanoformulated cabotegravir prodrug" @default.
- W3018289581 cites W1462610492 @default.
- W3018289581 cites W1968724247 @default.
- W3018289581 cites W1971281689 @default.
- W3018289581 cites W1991087280 @default.
- W3018289581 cites W2014233890 @default.
- W3018289581 cites W2059183805 @default.
- W3018289581 cites W2083017413 @default.
- W3018289581 cites W2155441883 @default.
- W3018289581 cites W2166967403 @default.
- W3018289581 cites W2290466312 @default.
- W3018289581 cites W2394662221 @default.
- W3018289581 cites W2401613699 @default.
- W3018289581 cites W2559683026 @default.
- W3018289581 cites W2580755549 @default.
- W3018289581 cites W2617514227 @default.
- W3018289581 cites W2738541296 @default.
- W3018289581 cites W2738765865 @default.
- W3018289581 cites W2746562707 @default.
- W3018289581 cites W2765161131 @default.
- W3018289581 cites W2766546877 @default.
- W3018289581 cites W2782437520 @default.
- W3018289581 cites W2783618712 @default.
- W3018289581 cites W2793931074 @default.
- W3018289581 cites W2794862768 @default.
- W3018289581 cites W2797192501 @default.
- W3018289581 cites W2801631100 @default.
- W3018289581 cites W2801859295 @default.
- W3018289581 cites W2802170264 @default.
- W3018289581 cites W2803243584 @default.
- W3018289581 cites W2810653208 @default.
- W3018289581 cites W2883638714 @default.
- W3018289581 cites W2884630921 @default.
- W3018289581 cites W2894851276 @default.
- W3018289581 cites W2899917447 @default.
- W3018289581 cites W2901789135 @default.
- W3018289581 cites W2904034213 @default.
- W3018289581 cites W2912227521 @default.
- W3018289581 cites W2937692116 @default.
- W3018289581 cites W2954698528 @default.
- W3018289581 cites W2969419768 @default.
- W3018289581 cites W2972081238 @default.
- W3018289581 cites W2972195192 @default.
- W3018289581 cites W2995020465 @default.
- W3018289581 cites W2997174977 @default.
- W3018289581 cites W3009494891 @default.
- W3018289581 cites W3009783198 @default.
- W3018289581 cites W3010513804 @default.
- W3018289581 doi "https://doi.org/10.1038/s41563-020-0674-z" @default.
- W3018289581 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7384935" @default.
- W3018289581 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32341511" @default.
- W3018289581 hasPublicationYear "2020" @default.
- W3018289581 type Work @default.
- W3018289581 sameAs 3018289581 @default.
- W3018289581 citedByCount "58" @default.
- W3018289581 countsByYear W30182895812020 @default.
- W3018289581 countsByYear W30182895812021 @default.
- W3018289581 countsByYear W30182895812022 @default.
- W3018289581 countsByYear W30182895812023 @default.
- W3018289581 crossrefType "journal-article" @default.
- W3018289581 hasAuthorship W3018289581A5006263846 @default.
- W3018289581 hasAuthorship W3018289581A5012857107 @default.
- W3018289581 hasAuthorship W3018289581A5018546819 @default.
- W3018289581 hasAuthorship W3018289581A5021809794 @default.
- W3018289581 hasAuthorship W3018289581A5023736838 @default.
- W3018289581 hasAuthorship W3018289581A5025385383 @default.
- W3018289581 hasAuthorship W3018289581A5027982894 @default.
- W3018289581 hasAuthorship W3018289581A5029066855 @default.
- W3018289581 hasAuthorship W3018289581A5035613509 @default.
- W3018289581 hasAuthorship W3018289581A5043422961 @default.
- W3018289581 hasAuthorship W3018289581A5051999877 @default.
- W3018289581 hasAuthorship W3018289581A5057200036 @default.
- W3018289581 hasAuthorship W3018289581A5058974129 @default.